Charles Sang has served as the Senior Vice President, Diagnostics, clonoSEQ at Adaptive Biotechnologies since April 2016. Prior to joining Adaptive Biotechnologies, Charles served as the Vice President of Global Diagnostics for Nanostring Technologies, Inc., a public biotechnology company, and as the Marketing Director at Seattle Genetics, a public biotechnology company. Charles holds a BA in Psychology and Human Services from National Louis University and a master’s degree in Social Work from New Mexico State University.